Loading…
Reported covered position: 2020: Paid Intern, Rep. Madeleine Dean
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CAMBER HEALTH via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to Medicaid fraud initiatives and Medicaid reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
THE MENTOR NETWORK via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Source: Senate LDA
Medicaid payment issues
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to Medicare, including dually eligible special needs plans, ACA Marketplace plans, and Medicaid.
Issues relating to Medicare, including dually eligible special needs plans, ACA Marketplace plans, and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ACADEMY OF OPHTHALMOLOGY via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Issues relating to Medicare including step therapy for Part B drugs and global surgical payments.
Issues relating to Medicare including step therapy for Part B drugs, global surgical payments, and drug shortages.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN ACADEMY OF OPHTHALMOLOGY via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicare including step therapy for Part B drugs and global surgical payments.
Issues relating to Medicare including step therapy for Part B drugs, global surgical payments, and drug shortages.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicare, including dually eligible special needs plans, ACA Marketplace plans, and Medicaid.
Issues relating to Medicare, including dually eligible special needs plans, ACA Marketplace plans, and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENTOR NETWORK via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Medicaid payment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBER HEALTH via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues relating to Medicaid fraud initiatives and Medicaid reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
CAMBER HEALTH via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to Medicaid fraud initiatives and Medicaid reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN ACADEMY OF OPHTHALMOLOGY via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to Medicare including step therapy for Part B drugs, global surgical payments, and drug shortages.
Issues relating to Medicare including step therapy for Part B drugs and global surgical payments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CAMBER HEALTH via MCDERMOTT+ LLC
2026 · first_quarter · RR
Issues relating to Medicaid fraud initiatives and Medicaid reimbursement.
THE MENTOR NETWORK via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Medicaid payment issues
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENTOR NETWORK via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Medicaid payment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENTOR NETWORK via MCDERMOTT+
2025 · third_quarter · Q3
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Medicaid payment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via MCDERMOTT+
2025 · third_quarter · 3A
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Issues relating to Medicare, including dually eligible special needs plans, Marketplace plans, and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENTOR NETWORK via MCDERMOTT+
2025 · second_quarter · 2A
Issues relating to Medicare, Medicaid, HCBS, and healthcare workforce.
Medicaid payment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · third_quarter · 3A
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE